Songjiang Ma, President at GYRE THERAPEUTICS, INC. (GYRE), sold 4,000 shares at $12.29 ($49K) on 2025-02-19, disclosed to the SEC on 2025-02-21.
Scheduled sale ($49k) by President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.29 | 2,000 | $25K | 49.8% |
| 2 | $12.40 | 2,000 | $25K | 50.2% |
| Total | $12.35 avg | 4,000 | $49K | 100% |
| Filing → |
| GYRE | SELL | 2025-05-22 | $44K | — | Filing → |
| GYRE | SELL | 2025-05-20 | $45K | — | Filing → |
| GYRE | SELL | 2025-05-16 | $22K | — | Filing → |